AU1996599A - Long-term survival and regeneration of central nervous system neurons - Google Patents
Long-term survival and regeneration of central nervous system neuronsInfo
- Publication number
- AU1996599A AU1996599A AU19965/99A AU1996599A AU1996599A AU 1996599 A AU1996599 A AU 1996599A AU 19965/99 A AU19965/99 A AU 19965/99A AU 1996599 A AU1996599 A AU 1996599A AU 1996599 A AU1996599 A AU 1996599A
- Authority
- AU
- Australia
- Prior art keywords
- regeneration
- long
- nervous system
- central nervous
- term survival
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/204—IL-6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2093—Leukaemia inhibitory factor [LIF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/13—Nerve growth factor [NGF]; Brain-derived neurotrophic factor [BDNF]; Cilliary neurotrophic factor [CNTF]; Glial-derived neurotrophic factor [GDNF]; Neurotrophins [NT]; Neuregulins
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98552197A | 1997-12-05 | 1997-12-05 | |
US08985521 | 1997-12-05 | ||
PCT/US1998/025663 WO1999029279A2 (en) | 1997-12-05 | 1998-12-03 | Long-term survival and regeneration of central nervous system neurons |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1996599A true AU1996599A (en) | 1999-06-28 |
Family
ID=25531561
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU19965/99A Abandoned AU1996599A (en) | 1997-12-05 | 1998-12-03 | Long-term survival and regeneration of central nervous system neurons |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1996599A (en) |
WO (1) | WO1999029279A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6245564B1 (en) | 1997-01-23 | 2001-06-12 | Cornell Research Foundation, Inc. | Method for separating cells |
US8263402B1 (en) | 1998-10-19 | 2012-09-11 | Cornell Research Foundation, Inc. | Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells |
US7468277B2 (en) | 1999-12-23 | 2008-12-23 | Cornell Research Foundation, Inc. | Enriched preparation of human fetal multipotential neural stem cells |
US7037493B2 (en) | 2000-05-01 | 2006-05-02 | Cornell Research Foundation, Inc. | Method of inducing neuronal production in the brain and spinal cord |
US7150989B2 (en) | 2001-08-10 | 2006-12-19 | Cornell Research Foundation, Inc. | Telomerase immortalized neural progenitor cells |
WO2003070189A2 (en) | 2002-02-15 | 2003-08-28 | Cornell Research Foundation, Inc. | Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein |
JP2006506970A (en) | 2002-07-12 | 2006-03-02 | ユニバーシティ オブ ワシントン | Methods and systems for extended in vitro culture of neurons |
WO2007048846A1 (en) * | 2005-10-27 | 2007-05-03 | Neuraxo Biopharmaceuticals Gmbh | Use of iron-chelating compounds, cyclic adenosine monophosphate-increasing compounds or combinations thereof for treating axonal lesions in the cns |
WO2007073151A1 (en) * | 2005-12-21 | 2007-06-28 | Stichting Katholieke Universiteit | Psoriatic skin equivalents |
BRPI0810063A2 (en) | 2007-04-20 | 2014-10-14 | Acucela Inc | COMPOUND, PHARMACEUTICAL COMPOSITION, AND METHODS FOR MODULATING CHROMOPHORUS FLOW IN A RETINOID CYCLE, TREATING A DISEASE OR DISHALM IN AN INDIVIDUAL TO INHIBIT DARK ADAPTATION TO THE FAST RAPIDINA CELL REGULINA RETINAL BOD POTORECEPTOR CELL, TO REDUCE ISCHEMIA IN AN EYE OF AN INDIVIDUAL, INHIBIT NEOVASCULARIZATION IN AN EYE OF AN INDIVIDUAL, AND INHIBIT DEGENERATION OF A RETINAL CELL |
AU2008271051C1 (en) | 2007-06-29 | 2012-10-04 | Acucela Inc. | Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
RU2541430C2 (en) | 2007-10-05 | 2015-02-10 | Акусела Инк. | Compositions and methods of treating neurodegenerative diseases |
CN104703598A (en) | 2012-01-20 | 2015-06-10 | 奥克塞拉有限公司 | Substituted heterocyclic compounds for disease treatment |
EP2970099A4 (en) | 2013-03-12 | 2016-12-21 | Acucela Inc | Substituted 3-phenylpropylamine derivatives for the treatment of ophthalmic diseases and disorders |
CN115404219B (en) * | 2022-09-09 | 2023-10-27 | 中国医学科学院医学生物学研究所 | Separation culture method of tree shrew retinal ganglion cells |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5667968A (en) * | 1989-08-30 | 1997-09-16 | Regeneron Pharmaceuticals, Inc. | Prevention of retinal injury and degeneration by specific factors |
US5584885A (en) * | 1994-04-28 | 1996-12-17 | Seckel; Brooke R. | Nerve regeneration chamber |
-
1998
- 1998-12-03 AU AU19965/99A patent/AU1996599A/en not_active Abandoned
- 1998-12-03 WO PCT/US1998/025663 patent/WO1999029279A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1999029279A2 (en) | 1999-06-17 |
WO1999029279A3 (en) | 1999-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1018987A4 (en) | Neocartilage and methods of use | |
AU7710198A (en) | Single pass lead and method of use | |
AU6717596A (en) | Body and head support platform | |
AU2002300785A1 (en) | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders | |
AU7885498A (en) | Selective acylation of epsilon-amino groups | |
AU7943398A (en) | Brain rescue instrument and method | |
AU2653199A (en) | Pseudospontaneous neural stimulation system and method | |
AU4967197A (en) | Photocatalyst having visible light activity and uses thereof | |
AU1616499A (en) | Chemokine variants and methods of use | |
AU1996599A (en) | Long-term survival and regeneration of central nervous system neurons | |
AU1372897A (en) | 2-amino-heterocycles and therapeutic uses therefor | |
HU9702242D0 (en) | Inozitol-glykanes of inzulin-like activity | |
EP0554215A3 (en) | Diacrylates and dimethacrylates | |
AU2909597A (en) | Use of hollow microcapsules | |
HUP0003206A3 (en) | Methods of preparing and purifying 9-nitro-20-camptothecin | |
AU6859096A (en) | Substituted cyclohexylamines as central nervous system agents | |
AU2058697A (en) | Treatment of sleep disorders | |
AU6695398A (en) | Immunoadhesins and methods of production and use thereof | |
EP0929313A4 (en) | Regulation of neural enzymes | |
AU4783196A (en) | Electrode arrangement and stimulation system | |
EP1011330A4 (en) | Central nervous system axon regeneration | |
AU2387097A (en) | Substituted benzylamines and their use for the treatment of depression | |
AU8023798A (en) | Wheelchair with improved suspension | |
AU3118297A (en) | Sok-1 and methods of use | |
AU6242498A (en) | Methods for treating central and peripheral nerve pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |